BP8 — BPH Global Share Price
0.000.00%
Last trade - 00:00- AU$1.10m
- AU$0.94m
- AU$0.00m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -991.63% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 1.56 | 0.73 | 8.5 | 0.49 | 0 | n/a | n/a | -74.08% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BPH Global Ltd is a plant-focused biotechnology company. The Company is focused on producing foods and products that deliver Traditional Chinese Medicine-based health outcomes. It focuses on the research and development, production and commercialization of plant-based products, including seaweed and sea plants to produce sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients (including cannabidiol (CBD) extracted from Hemp) for utilization in the food, nutrition, healthcare, cosmetics, and personal care industries. Its principal business focus is on Singapore, Australia, Southeast Asia, and Chinese markets. The Company produces its products through various plants, which include Caulerpa lentillifera, Dendrobium officinale, Resina and Cannabis sativa. It is also into the sales and distribution of bird's nest products in China. Its subsidiaries include Stemcell United Pte Ltd, Stemcell Essential Pte Ltd, and SCU Southeast Asia Sdn Bhd, SCU (HK) Ltd.
Directors
- Paul Rosen NEC (55)
- Philip Gu CEO
- Chow-Yee Koh CFO
- Elizabeth Spooner SEC
- Huan Qing Gu DRC
- Francesco Cannavo NED
- Yanhua Huang NED
- Qi Lu NED
- Paul Stephenson NED
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 25th, 1984
- Public Since
- June 13th, 2000
- No. of Employees
- 31
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 367,112,622.8
- Address
- Level 5, 126 Phillip Street, SYDNEY, 2000
- Web
- https://scu.com.sg/
- Phone
- +61 280721400
- Auditors
- HLB Mann Judd (NSW) Pty Ltd.
Upcoming Events for BP8
BPH Global Ltd Annual Shareholders Meeting
Similar to BP8
Actinogen Medical
Australian Stock Exchange - SEATS
Adalta
Australian Stock Exchange - SEATS
Algorae Pharmaceuticals
Australian Stock Exchange - SEATS
Alterity Therapeutics
Australian Stock Exchange - SEATS
Amplia Therapeutics
Australian Stock Exchange - SEATS
FAQ
What is the BPH Global share price?
As of Today at 13:42 UTC, shares in BPH Global are trading at AU$0.00. This share price information is delayed by 15 minutes.
How has the BPH Global share price performed this year?
Shares in BPH Global last closed at AU$0.00 and the price had moved by -76.67% over the past 365 days. In terms of relative price strength the BPH Global share price has underperformed the ASX All Ordinaries Index by -78.58% over the past year.
What are the analyst and broker recommendations for BPH Global?
There is no consensus recommendation for this security.
What is the BPH Global dividend yield?
BPH Global does not currently pay a dividend.
Does BPH Global pay a dividend?
BPH Global does not currently pay a dividend.
When does BPH Global next pay dividends?
BPH Global does not currently pay a dividend.
How do I buy BPH Global shares?
To buy shares in BPH Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BPH Global?
As of the previous close price of AU$0.00, shares in BPH Global had a market capitalisation of AU$1.28m.
Where are BPH Global shares listed?
Here are the trading details for BPH Global:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: BP8
What kind of share is BPH Global?
Based on an overall assessment of its quality, value and momentum BPH Global is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BPH Global share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the BPH Global share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BPH Global. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -54.75%.
As of the last closing price of AU$0.00, shares in BPH Global were trading -69.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BPH Global PE Ratio?
The BPH Global PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BPH Global?
BPH Global's management team is headed by:
- Paul Rosen - NEC
- Philip Gu - CEO
- Chow-Yee Koh - CFO
- Elizabeth Spooner - SEC
- Huan Qing Gu - DRC
- Francesco Cannavo - NED
- Yanhua Huang - NED
- Qi Lu - NED
- Paul Stephenson - NED